Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: The Difficulty in Interpreting Proof-of-Concept Studies

by Jessica Gordon, Robert Spiera
Published 2011-01-01

Design of the Tocilizumab in Giant Cell Arteritis Trial

by Sebastian H. Unizony, Bhaskar Dasgupta, Elena Fisheleva, Lucy Rowell, Georg Schett, Robert Spiera, Jochen Zwerina, Olivier Harari, John H. Stone
Published 2013-01-01

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

by Sebastian Unizony, Timothy J. McCulley, Robert Spiera, Jinglan Pei, Paris N. Sidiropoulos, Jennie H. Best, Christine Birchwood, Andrey Pavlov, John H. Stone
Published 2021-01-01

Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis

by Kasia Owczarczyk, Matthew D. Cascino, Cecile Holweg, Gaik W. Tew, Ward Ortmann, Timothy Behrens, Thomas Schindler, Carol A. Langford, E. William St. Clair, Peter A. Merkel, Robert Spiera, Philip Seo, Cees G.M. Kallenberg, Ulrich Specks, Noha Lim, John Stone, Paul Brunetta, Marco Prunotto, the RAVE-ITN Research Group
Published 2020-09-01

Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis.

by Paul A Monach, Philipp Kümpers, Alexander Lukasz, Gunnar Tomasson, Ulrich Specks, John H Stone, David Cuthbertson, Jeffrey Krischer, Simon Carette, Linna Ding, Gary S Hoffman, David Iklé, Cees G M Kallenberg, Nader A Khalidi, Carol A Langford, Philip Seo, E William St Clair, Robert Spiera, Nadia Tchao, Steven R Ytterberg, Marion Haubitz, Peter A Merkel
Published 2012-01-01